Author:
Kouzuki Minoru,Miyamoto Madoka,Tanaka Nobuto,Urakami Katsuya
Abstract
Abstract
Background
In the present study, we examined the distinguishing ability of a mild cognitive impairment (MCI) assessment tool for rapid screening using a computer (MARC) for Alzheimer’s disease dementia (ADD), MCI, and non-demented controls (NDC) with no cognitive impairment, as well as its validity and reliability, as part of a preliminary trial for the development of the tool.
Methods
A total of 64 participants (23 in the ADD group, 17 in the MCI group, and 24 in the NDC group) were analyzed. The participants were administered MARC and a pre-existing computerized Alzheimer’s dementia screening test (MSP), and 31 participants (14 in the MCI group, 17 in the NDC group) were readministered MARC within 4 months from the first test.
Results
The median (interquartile range) test time for MARC was 401 (350–453) s. Total MARC scores were significantly worse in the MCI and ADD groups than in the NDC group (p < 0.05 and p < 0.01, respectively). In the receiver operating characteristic (ROC) analysis, the area under the ROC curve (AUC) when comparing the NDC and MCI groups was 0.866 (95% CI, 0.759–0.974), when comparing the NDC and AD groups was 0.989 (95% CI, 0.970–1.000), and when comparing the MCI and AD groups was 0.889 (95% CI, 0.790–0.988). Furthermore, there was a significant correlation with the results of the existing test, MSP (r = 0.839, p < 0.001). In addition, the intraclass correlation coefficient (ICC) (1,1) when the first and second MARC scores were compared was 0.740 (95% CI, 0.529–0.865; p < 0.001).
Conclusions
MARC is considered capable of distinguishing MCI with high accuracy. The tool has good validity and reliability, and it can be administered in a short period of time without the need for a specialist.
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine
Reference43 articles.
1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94.
2. Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement. 2012;8(1):14–21.
3. Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753–72.
4. Asada T. Prevalence of dementia in urban areas and functional disability in dementia (in Japanese). http://www.tsukuba-psychiatry.com/wp-content/uploads/2013/06/H24Report_Part1.pdf. Published 2013. Accessed 25 Aug 2022.
5. Ninomiya T, Nakaji S, Maeda T, Yamada M, Mimura M, Nakashima K, et al. Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan prospective studies collaboration for aging and dementia (JPSC-AD). Environ Health Prev Med. 2020;25(1):64.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献